Companies racing for a coronavirus cure have moved to lofty valuations. Morningstar analyst Alex Morozov is looking for lesser-known healthcare names
Morningstar Guest: Alex Morozov - Director of Equity Research, EMEA, Morningstar
7.75K subscribers
No comments:
Post a Comment